Cell & gene therapy development

From scientific
potential to
clinical possibility.

CMC strategy and preclinical development, supported by process, analytical, and hands-on expertise for the journey to the clinic.

Conceptual cell imagery
CMC strategyProcess developmentAnalytical developmentPreclinical strategy

Expertise, connected

The right expertise.
At the right stage.

Cell and gene therapy development brings complex questions. We connect the scientific, technical, and operational expertise to help you answer them.

Explore all services
Shape the CMC and preclinical strategy

Connect product requirements and CMC planning with preclinical development, including model selection, IND-enabling study design, and CRO selection and management.

Build the process and the evidence

Develop a deeper understanding of the process and the analytical methods that support product characterization.

Connect partners and execution

Bring structure to technology transfer, operating practices, and the selection and oversight of development partners.

Turn experiments into understanding

Use QbD, experimental design, and laboratory studies to identify what matters and inform the next development decision.

Our approach

Scientific understanding.
Practical progress.

A connected approach to product development, with the right questions, purposeful experiments, and evidence to guide each step.

Frame the program

Define product goals, map development gaps, and identify the decisions ahead.

Build understanding

Connect risk assessment, DoE, and analytics to investigate the factors that matter.

Prepare for transfer

Align processes, methods, materials, and partners around a practical execution plan.

Advance with evidence

Use process characterization and comparability to support informed development decisions.

Wet lab services

Strategy, with
sleeves rolled up.

Practical laboratory expertise brings development plans into the experiment. Connect your strategy with the studies needed to move it forward.

Explore our lab capabilities
Cell engineering & optimization
Bioreactor & media development
Scale-down models & experimental design
Technology transfer & device evaluation

The people behind the science

Experience you can
work alongside.

Scientists and development leaders who bring complementary expertise to the challenges of cell and gene therapy.

Meet the full team
Panos Chrysanthopoulos, PhD

Panos Chrysanthopoulos, PhD

Co-founder & Director

Calley Hirsch, PhD

Calley Hirsch, PhD

Co-founder & Director

Jessica Schwaber, PhD

Jessica Schwaber, PhD

Senior Partner & Head of Business Development

Perspectives & resources

Ideas for the decisions ahead.

Browse resources

Expert workshop

CMC strategy from concept to clinical translation.

A discussion of the development considerations that connect early concepts to clinical products and beyond.

Explore the workshop

Industry perspective

What matters when choosing a gene-editing platform?

Insights from a voice-of-customer survey exploring the priorities of cell and gene therapy developers.

Explore the findings

Your next development decision

Let’s move your
program forward.

Bring us your questions. We’ll help define the next steps.

Discuss your program